RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,278,477 | -50.2% | 865,455 | -2.4% | 0.00% | -57.1% |
| Q2 2023 | $14,601,346 | 0.0% | 886,542 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $14,601,346 | +19.8% | 886,542 | +8.6% | 0.01% | +16.7% |
| Q4 2022 | $12,191,010 | -99.9% | 815,998 | -1.6% | 0.01% | -40.0% |
| Q3 2022 | $18,557,257,000 | +41.7% | 829,560 | +6.1% | 0.01% | +42.9% |
| Q2 2022 | $13,092,520,000 | -23.9% | 781,643 | +36.1% | 0.01% | 0.0% |
| Q1 2022 | $17,193,199,000 | -9.0% | 574,447 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $18,894,574,000 | +155.8% | 615,258 | +162.7% | 0.01% | +133.3% |
| Q3 2021 | $7,385,776,000 | -23.0% | 234,246 | -10.7% | 0.00% | -25.0% |
| Q2 2021 | $9,595,398,000 | -34.8% | 262,241 | -38.4% | 0.00% | -42.9% |
| Q1 2021 | $14,707,841,000 | -26.9% | 425,451 | -12.2% | 0.01% | -22.2% |
| Q4 2020 | $20,131,456,000 | +85.7% | 484,395 | +90.3% | 0.01% | +50.0% |
| Q3 2020 | $10,839,538,000 | – | 254,509 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,130,605 | $96,141,000 | 3.49% |
| Casdin Capital, LLC | 3,857,253 | $118,456,000 | 3.34% |
| Grace Capital | 183,112 | $5,623,000 | 3.34% |
| Boxer Capital, LLC | 2,669,132 | $81,969,000 | 3.18% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $856,961,000 | 2.50% |
| Integral Health Asset Management, LLC | 225,000 | $6,910,000 | 1.91% |
| Fernwood Investment Management, LLC | 185,063 | $5,683,000 | 1.86% |
| EcoR1 Capital, LLC | 1,779,084 | $54,636,000 | 1.74% |
| HARVARD MANAGEMENT CO INC | 541,124 | $16,618,000 | 1.56% |
| Bellevue Group AG | 4,105,962 | $126,094,000 | 1.30% |